Adding an immune checkpoint inhibitor (ICI) to chemotherapy for advanced prostate cancer failed to improve survival as ...

A 68-year-old man with prostate cancer develops penile metastases, a rare but serious complication, reinforcing the need for ...

A shorter, higher-dose radiation treatment for prostate cancer is just as safe and effective as conventional radiotherapy, ...

When it comes to lung cancer, we know of more than 30 substances that are carcinogenic. But when researchers began ...

This groundbreaking finding suggests that Telomir-1 may selectively benefit healthy cells while suppressing malignant growth, challenging the assumption that telomere-elongating drugs inherently ...

A new large-scale study co-led by UCLA Health Jonsson Comprehensive Cancer Center investigators provides the strongest ...

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment ...

Mateship, support, information: this and more are what two cancer survivors are hopeful a dedicated prostate cancer nurse can ...

Zydus Lifesciences received final USFDA approval to manufacture Apalutamide tablets for prostate cancer, following last ...

Since its European debut in 2021 [2], Radelumin has become a widely adopted tool for early detection, staging, and recurrence ...

When it comes to lung cancer, we know of more than 30 substances that are carcinogenic. But when researchers began ...

A new artificial intelligence tool could help doctors determine which prostate cancer patients are most likely to benefit ...